ライフサイエンスコーパス: mice were treated with

1 Male and female mice were treated with 0.2 g/kg intratracheal silica, and lun

2 When prediabetic NOD mice were treated with 2-deoxyglucose to block aerobic glycol

3 This phenomenon was corroborated when WT mice were treated with a CB2-specific antagonist that caused

4 cted NSG mice, no hyperinfection was observed even when the mice were treated with a monoclonal antibody to eliminate res

5 Groups of mice were treated with a prolonged course of non-absorbable a

6 fore, wild-type (WT) and AMPK-beta1-knockout (AMPK-beta1KO) mice were treated with a salsalate dose resulting in clinical

7 Ten-month-old 5xfAD mice were treated with a selective CSF1R inhibitor for 1 mont

8 C57Bl/6 mice were treated with a single dose of irradiation and subje

9 We used a murine model of simulated menses; mice were treated with a single dose of the nonaromatizable a

10 Four-day-old male mice were treated with AFB1 using a regimen that induced HCC

11 Six weeks after Pkd1 global gene knockout, the mice were treated with Agt-ASO (66 mg/kg/wk), lisinopril (100

12 Adult mice were treated with an angiotensin converting enzyme (ACE)

13 L2-IL5(OXA) EoE mice were treated with anti-GM-CSF neutralizing antibody or i

14 meninges is influenced by interactions with CD11c(+) cells, mice were treated with anti-LFA-1 Abs to reduce the number of

15 C57BL/6 mice were treated with AT-RvD1 and infected with live NTHi.

16 When mice were treated with Au-ACRAMTU-PEt3 during viral infection

17 DIO mice were treated with bilirubin or vehicle for 14 days.

18 No Eng was detected after mice were treated with caspofungin, a beta-1,3-glucan synthas

19 Prior to A. alternata extract, challenged WT mice were treated with cicaprost.

20 ation, 2',3'-cyclic-nucleotide 3'-phosphodiesterase-EGFP(+) mice were treated with cuprizone, and OPCs were sorted from t

21 period, at a time when spontaneous seizures were frequent, mice were treated with diphtheria toxin to ablate peri-insult

22 months of age, tet-off amyloid precursor protein transgenic mice were treated with doxycycline (dox) to suppress further

23 Cholesterol-fed, LDL receptor-deficient mice were treated with either an anti-Apob antisense oligonuc

24 Sham-surgery and SCNX mice were treated with either Meth (1.2 mg/kg, i.p.) or vehic

25 Three-week-old mice were treated with either vehicle, CyA (2 mg/kg per day),

26 Seven-day-old mice were treated with exogenous VEGFC for 2 weeks on the pre

27 of BH4 deficiency in disease phenotypes, 12-month-old Fabry mice were treated with gene transfer-mediated ERT or substrat

28 However, when RenTgMK mice were treated with hydralazine (a smooth muscle relaxant)

29 Human TNF transgenic (hTNF-Tg) mice were treated with infliximab after development of arthri

30 Tumor-bearing mice were treated with JQ1 (50 mg/kg daily for 21 or 28 days)

31 3 failed to protect and even exacerbated liver injury after mice were treated with lipopolysaccharide/GalN and a pan-casp

32 Utilizing a murine calvarial model, Mk2(+/+) and Mk2(-/-) mice were treated with live A. actinomycetemcomitans bacteria

33 Young (3-month-old) mice were treated with losartan ( approximately 10 mg/kg/d, 4

34 264.7, mouse primary lung monocytes/macrophages, and BALB/c mice were treated with LPS/IFN-gamma, in the presence and abs

35 the role of miR-497 on angiogenesis, VEGFR2-luc transgenic mice were treated with miR-497 mimic and applied to monitor t

36 BALB/c mice were treated with monoclonal anti-C5 i.p. on day 3 or 6

37 Selected mice were treated with neutralizing Abs to IL-33 or recombina

38 (0.054 g +/- 0.041 vs 0.223 g +/- 0.112, respectively; six mice were treated with pazopanib and seven were control mice;

39 immune responses to sequential IAV infections, adult female mice were treated with placebo or one of two progestins, P4 o

40 Control B05 mice were treated with rAAVs expressing a control artificial

41 Female KO and congenic wild type (WT) mice were treated with racemic PCB 136, and levels and chiral

42 When Tm infected mice were treated with rapamycin, DCLK1 and IL-25 expression

43 In this study, newborn CBS-knockout (KO) mice were treated with recombinant polyethyleneglycolylated h

44 ovariectomized (OVX) female mice, and estrogen-treated male mice were treated with silica, and lung injury was assessed.

45 In this study, humanized mice were treated with Smoothened Agonist (SAG), a Sonic Hedg

46 Once colitis was established, mice were treated with solvent, EPO or the selective IRR agon

47 To further evaluate these findings, CaMKIIdeltaC transgenic mice were treated with the beta1-AR blocker metoprolol (270 m

48 C57Bl/6 mice were treated with the NO synthase inhibitor L-N(G)-nitro

49 Immediately after the surgery, these mice were treated with the Tgfbr2 inhibitor losartan for 8 we

50 Adult mice were treated with vehicle or tamoxifen and euthanized at